Watanabe K |
[PGF synthetase]. |
1986 |
Seikagaku |
pmid:3084680
|
Inoué S |
[Sleep substances: their roles and evolution]. |
1983 |
Seikagaku |
pmid:6355327
|
Satoh T |
[Cysteine-mediated signaling pathway by a novel electrophilic compound, NEPP11]. |
2007 |
Seikagaku |
pmid:17319510
|
Moniot B et al. |
Male specific expression of lipocalin-type prostaglandin D synthase (cPTGDS) during chicken gonadal differentiation: relationship with cSOX9. |
2008 |
Sex Dev |
pmid:18577876
|
Li LH and Ku BS |
[Regulation of SWS by hormones and cytokines]. |
2000 |
Sheng Li Ke Xue Jin Zhan |
pmid:12532764
|
Abdelrahman M et al. |
The peroxisome proliferator-activated receptor-gamma ligand 15-deoxyDelta12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock. |
2004 |
Shock |
pmid:15545828
|
Hickson-Bick DL et al. |
The response of neonatal rat ventricular myocytes to lipopolysaccharide-induced stress. |
2006 |
Shock |
pmid:16680021
|
Liu J et al. |
Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes. |
2009 |
Shock |
pmid:19174742
|
Genovese T et al. |
Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury. |
2008 |
Shock |
pmid:18628687
|
Monroy MA et al. |
THE PPARgamma ligand 15d-PGJ2 modulates macrophage activation after injury in a murine trauma model. |
2007 |
Shock |
pmid:17510607
|
Zingarelli B et al. |
Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt. |
2007 |
Shock |
pmid:17589386
|
Guyton K et al. |
Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli. |
2003 |
Shock |
pmid:12813370
|
Kaplan J et al. |
Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells. |
2007 |
Shock |
pmid:17621259
|
Kaplan JM et al. |
15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock. |
2005 |
Shock |
pmid:15988322
|
Piraino G et al. |
Synergistic effect of peroxisome proliferator activated receptor-gamma and liver X receptor-alpha in the regulation of inflammation in macrophages. |
2006 |
Shock |
pmid:16878022
|
Hovsepian E et al. |
15-deoxy-Delta12,14 prostaglandin GJ2 but not rosiglitazone regulates metalloproteinase 9, NOS-2, and cyclooxygenase 2 expression and functions by peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms in cardiac cells. |
2010 |
Shock |
pmid:19997048
|
Yeh CH et al. |
Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators. |
2006 |
Shock |
pmid:16912651
|
Haack M et al. |
Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. |
2007 |
Sleep |
pmid:17910386
|
Urade Y and Hayaishi O |
Prostaglandin D2 and sleep/wake regulation. |
2011 |
Sleep Med Rev |
pmid:22024172
|
Tang J et al. |
Aspirin treatment improved mesenchymal stem cell immunomodulatory properties via the 15d-PGJ2/PPARγ/TGF-β1 pathway. |
2014 |
Stem Cells Dev. |
pmid:24730450
|